Gastrointestinal Stromal Tumors Therapy
New gastrointestinal stromal tumors therapy research from American University of Beirut, Department of Surgery outlined
Published in Cancer Weekly, June 12th, 2007
Data detailed in "Disease progression following imatinib failure in gastrointestinal stromal tumors: role of surgical therapy" have been presented. "Gastrointestinal stromal tumors (GISTs) represent the most common mesenchymal neoplasms of the GI tract. The optimal management of GISTs has been evolving rapidly over the past 5 years and depends on proper histopathologic and radiologic diagnosis as well as appropriate multidisciplinary medical and surgical treatments," scientists writing in the journal Oncologist report.
"Complete surgical resection of primary localized GIST with negative margins remains the best therapeutic option today. In the setting of locally...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-06-12)
More Articles from Cancer Weekly
- Cancer Vaccines
OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients - Lung Cancer
Clinical data suggest potential versatility of Alimta-based regimens in lung cancer - Bird Flu
State Funding Supports Wistar Institute Vaccine Center: $4.2 Million to Pursue Universal Influenza Vaccine, Train Minority Students - Bladder Cancer
Viventia Biotech Inc. (VBI.TO) Reports Final Vicinium Phase I/II Bladder Cancer Data at the American Urological Association Annual Meeting - Bone Research
Vidacare Announces Release of Novel Bone Marrow Aspiration System for Hematology/Oncology - Brain Cancer
The Tug McGraw Foundation and Accelerate Brain Cancer Cure Collaborate to Fund Innovative UCSF Brain Tumor Research - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
